Jinling Hospital, China
Clinical trials sponsored by Jinling Hospital, China, explained in plain language.
-
Promising combo aims to shrink pancreatic tumors before surgery
Disease control Not yet recruitingThis study tests whether adding the drug adebrelimab to standard chemotherapy before surgery can help shrink pancreatic tumors and improve complete removal. About 30 adults with resectable pancreatic cancer will receive this combination. The goal is to see if it increases the cha…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo attack shrinks untreatable liver tumors
Disease control Not yet recruitingThis study tests a powerful mix of treatments for people with liver cancer that cannot be surgically removed. It combines two types of local therapy (TACE and SBRT) with an immunotherapy drug and a targeted pill (donafenib). The goal is to see if this combination can shrink tumor…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 12, 2026 13:41 UTC